THE ACCESS — AN ATLAS OF THE U.S. DIALYSIS SYSTEMPLATE VIII — FIRST STATE — 07|2026

The Benchmark Pipeline

A DRAWN MAP · WHERE A STANDARD COMES FROM, AND WHAT IT LOSES BECOMING A RULE

Where a clinical standard comes from and what it loses on the way to becoming a rule: the evidence engine on science’s irregular clock, the measure factory that turns a value into a proxy, the payment clock that lands it two years after the care — and the hemoglobin spine, worked end to end.

HOW TO READ · 1PX CARBON = EVIDENCE AND PRACTICE · BLUE = THE MEASURE FACTORY AND THE PAYMENT CLOCK · 2PX = A PRESSURE POINT · HAIRLINE BOX = MARGIN NOTE
AN ATLAS OF THE U.S. DIALYSIS SYSTEMTALL GRAMMAR — PIPELINE + WORKED EXAMPLEPLATE VIII
The Benchmark PipelineFIRST STATE · ED. 001 · 07|2026
MARGIN — RESERVED FOR THE HAND
scored inarrives asvia annual rulemeasure goes livearrives asworked exampleevidence base citedREGION 4 — THE THREE FACES: the same number arrives three waystranslates for thispatientREGULATORY FLOORQIP measures + CfCV-tagscohort grammar —punitiveTHE FACILITYtranslation layerbetweencohort and personBEST-PRACTICE TARGETKDOQI / KDIGOcohort grammar —aspirationalINDIVIDUALIZED GOALplan of careperson grammar —justified deviationTHE STANDARDIZATIONTENSION:QAPI manages thecohort.The POC defends theperson.Same data table,transposed —third appearance of thedevicefrom the Lab Routingmap.A clinic that cannotsay which faceit is managing to ismanaging to none.WORKED EXAMPLE — THE HEMOGLOBIN SPINE: a value becomes a shadowtriggersexecutes asESA trialsCHOIR + CREATE 2006TREAT 2009higher Hgb targets =harm signalFDA ESA label change2011no target — lowest dosesufficientto avoid transfusionStatute hard-wires thelink:QIP anemia measuresmust reflectFDA-approved labeling42 CFR 413.178Hgb greater than 12clinical measureREMOVED for PY2017Anemia now measured byits shadows:transfusions — STrRhospitalizations — SHRreadmissions — SRREven the shadowoscillates:STrR clinical PY2018 →reporting → clinicalagain,as a rate, PY2025THE TWIST ON THE LAGTHESIS:not just delay —translation.Trials 2006 → label2011 → rule 2014 →payment effect PY2017:an 11-yearbench-to-payment-effectarc.And at the end of it,no hemoglobinnumber is scoredanywhere in the QIP.The regulator measuresconsequences,not values.REGION 3 — THE PAYMENT CLOCK: regulation's calendar, fixedclaims + EQRS datapayment year = CY + 2Performance periodone calendar yearFacility TotalPerformance ScoreUp to minus 2 percentpayment reductionin the payment yearTIME DECODER:care delivered CY2026 →scored 2027 → paidPY2028.Payment year = calendaryear + 2.Today's chair-sidedecision meets itsfinancial consequencetwo years out.REGION 2 — THE MEASURE FACTORY: where a value becomes a proxyCMS measure developmentUM-KECC contractorConsensus-based entityendorsementNQF, then Battelle PQMsince 2023Measures UnderConsiderationpre-rulemaking reviewAdoption via annualESRD PPS ruleTHE RULE MACHINECoverage Map, Region 3TRANSLATION LOSS:what survives thefactory is whatclaims + EQRS cancount.A clinical valuebecomes a proxy.A proxy becomes ascore.REGION 1 — THE EVIDENCE ENGINE: science's clock, irregularClinical trials +observational researchKDIGO global guidelinesevidence-triggeredupdatesno fixed cadenceNKF-KDOQIUS commentaries +practice guidelinesBest-practice diffusionjournals, conferences,medical directorsSCIENCE'S CLOCK:guidelines update whenevidenceforces them to —irregular,sometimes a decadeapart.Publication is notadoption.
KEY
EVIDENCE / PRACTICE
THE FACTORY & THE CLOCK — BLUE
PRESSURE POINT
MARGIN NOTE
THE ACCESS · 07|2026
ED. 001 · DRAWN MAP SRC: 42 CFR 413.178 · CMS QIP RULEMAKING · KDOQI / KDIGO
PLATE VIII · FIRST STATE DRAWN UNDER THE AUTHOR’S DIRECTION · VERIFIED AGAINST THE ATLAS DATASET
AWAITING THE AUTHOR’S PASS